首页> 外文期刊>The Journal of Urology >Low clinical stage renal cell carcinoma: relevance of microvascular tumor invasion as a prognostic parameter.
【24h】

Low clinical stage renal cell carcinoma: relevance of microvascular tumor invasion as a prognostic parameter.

机译:低临床期肾细胞癌:微血管肿瘤浸润作为预后参数的相关性。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: Renal cell carcinoma is a tumor with unpredictable behavior and defining reliable prognostic factors would be extremely valuable in the clinical setting. Tumor stage, nuclear grade and tumor cell type are the main prognostic clinical parameters available. In this study we evaluated the role of microvascular involvement in the primary lesion for predicting tumor behavior in patients with low stage clinical disease. MATERIALS AND METHODS: A total of 95 patients with clinically localized renal cell carcinoma (stages T1-T2 Nx M0) underwent radical nephrectomy and/or nephron sparing surgery, and were followed for a median of 45 months. The impact of microvascular tumor invasion on disease progression and its correlation with known pathological outcomes (tumor size, nuclear grade and cell type) were studied. RESULTS: Microvascular tumor invasion was observed in 24 patients (25%), of whom 50% had disease recurrence. Of the 71 patients without microvascular invasion only 4 (6%) showed tumor recurrence. When microvascular invasion was correlated with other histological parameters, a significant statistical association was noted with tumor diameter, perirenal fat invasion, macroscopic extension to the renal vein, nuclear grade, lymph node metastasis and sarcomatous elements in the tumor. Multivariate analysis showed that microvascular invasion and the involvement of regional lymph nodes were independent predictors of disease recurrence. Concerning cancer specific survival, microvascular invasion and perirenal fat infiltration were the only factors related to death. CONCLUSIONS: Microvascular invasion is an independent and relevant clinical prognostic parameter for low clinical stage renal cell carcinoma.
机译:目的:肾细胞癌是一种行为无法预测的肿瘤,确定可靠的预后因素在临床中将非常有价值。肿瘤分期,核分级和肿瘤细胞类型是可用的主要预后临床参数。在这项研究中,我们评估了微血管受累在原发灶中对于预测低期临床疾病患者的肿瘤行为的作用。材料与方法:共有95例临床定位的肾细胞癌(T1-T2 Nx M0期)患者接受了根治性肾切除术和/或保留肾单位的手术,平均随访时间为45个月。研究了微血管肿瘤浸润对疾病进展的影响及其与已知病理结果(肿瘤大小,核级和细胞类型)的相关性。结果:24例患者(25%)观察到微血管肿瘤浸润,其中50%复发。在没有微血管浸润的71例患者中,只有4例(6%)显示出肿瘤复发。当微血管浸润与其他组织学参数相关时,与肿瘤直径,肾周脂肪浸润,肾静脉肉眼可见的扩展,核分级,淋巴结转移和肿瘤中的肉瘤成分之间存在显着的统计学联系。多因素分析表明,微血管浸润和局部淋巴结受累是疾病复发的独立预测因子。关于癌症的特异性存活,微血管浸润和肾周脂肪浸润是与死亡相关的唯一因素。结论:微血管浸润是低临床期肾细胞癌的独立且相关的临床预后参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号